Amoroso Michael's Form 4 filing
Precision Biosciences Inc (DTIL) · filed Jan 22, 2025
- Accession no.
- 0000950170-25-008013
- Filed
- Jan 22, 2025
- Trade date
- Jan 20-21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $172.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Amoroso MichaelCIK 0001830874 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2025 | Common Stock | MOption exerciseAcquired | +115,388 | – | – | 143,925 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −36,838 | $4.67 | −$172,033.46 | 107,087 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2025 | Common Stock | MOption exerciseDisposed | −8,888 | $0.00 | $0 | 8,888 | Direct | |
| Jan 20, 2025 | Common Stock | MOption exerciseDisposed | −37,079 | $0.00 | $0 | 74,138 | Direct | |
| Jan 20, 2025 | Common Stock | MOption exerciseDisposed | −69,421 | $0.00 | $0 | 138,842 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.